US 8492347
Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus
granted A61KA61K38/10A61P
Quick answer
US patent 8492347 (Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus) held by The Regents of the University of California expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/10, A61P, A61P37/06